MedTrace Logo

Gamma-delta Tocotrienol as Potential Maintenance Treatment in Women With Metastatic Breast Cancer

NCT01571921 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2016-09-14

No results posted yet for this study

Summary

Twelve healthy volunteers who fit the inclusion and exclusion criteria and provide written informed consent to participate in the trial will be recruited to compare the rate and extent of absorption and pharmacokinetics of the newly formulated Gamma-Delta formulation with TRF.

Conditions

  • Healthy Subjects

Interventions

DIETARY_SUPPLEMENT

Gamma-Delta Tocotrienol and Tocotrienol Rich Fraction

Single oral TRF or Gamma-Delta Tocotrienol dosage

Sponsors & Collaborators

  • University of Malaya

    collaborator OTHER

  • Malaysia Palm Oil Board

    lead OTHER_GOV

Principal Investigators

  • Nur Aishah Mohd Taib · University of Malaya

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-01-31
Completion
2013-02-28

Countries

  • Malaysia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01571921 on ClinicalTrials.gov